Morgan Stanley’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,396,216
Closed -$24.5M 8399
2021
Q3
$24.5M Buy
1,396,216
+1,073,340
+332% +$18.8M ﹤0.01% 1876
2021
Q2
$3.13M Buy
322,876
+10,532
+3% +$102K ﹤0.01% 4245
2021
Q1
$3.35M Buy
312,344
+31,405
+11% +$337K ﹤0.01% 3823
2020
Q4
$4.13M Buy
280,939
+24,658
+10% +$363K ﹤0.01% 3466
2020
Q3
$3.64M Buy
256,281
+94,736
+59% +$1.35M ﹤0.01% 3028
2020
Q2
$1.31M Sell
161,545
-27,381
-14% -$222K ﹤0.01% 3954
2020
Q1
$764K Sell
188,926
-1,681,078
-90% -$6.8M ﹤0.01% 4129
2019
Q4
$1.93M Buy
1,870,004
+709,906
+61% +$731K ﹤0.01% 4075
2019
Q3
$356K Buy
1,160,098
+114,400
+11% +$35.1K ﹤0.01% 4840
2019
Q2
$343K Buy
1,045,698
+275,800
+36% +$90.5K ﹤0.01% 4787
2019
Q1
$508K Buy
769,898
+246,743
+47% +$163K ﹤0.01% 4541
2018
Q4
$894K Buy
523,155
+166,500
+47% +$285K ﹤0.01% 4360
2018
Q3
$2.07M Buy
356,655
+71,860
+25% +$417K ﹤0.01% 3970
2018
Q2
$1.71M Buy
284,795
+58,900
+26% +$353K ﹤0.01% 4222
2018
Q1
$1.63M Buy
225,895
+65,040
+40% +$468K ﹤0.01% 4181
2017
Q4
$1.17M Buy
160,855
+99,985
+164% +$725K ﹤0.01% 4438
2017
Q3
$314K Buy
60,870
+54,100
+799% +$279K ﹤0.01% 5137
2017
Q2
$29K Buy
6,770
+6,070
+867% +$26K ﹤0.01% 6006
2017
Q1
$4K Buy
+700
New +$4K ﹤0.01% 6398
2016
Q4
Sell
-400
Closed -$6K 6599
2016
Q3
$6K Buy
+400
New +$6K ﹤0.01% 6215
2016
Q2
Sell
-4,889
Closed -$45K 6736
2016
Q1
$45K Buy
4,889
+3,977
+436% +$36.6K ﹤0.01% 5655
2015
Q4
$11K Buy
912
+273
+43% +$3.29K ﹤0.01% 6218
2015
Q3
$8K Hold
639
﹤0.01% 6305
2015
Q2
$14K Sell
639
-611
-49% -$13.4K ﹤0.01% 6227
2015
Q1
$25K Buy
+1,250
New +$25K ﹤0.01% 5994